Kitagaki, H., Maeda, H. (2026). Dose optimization in FDA oncology drug approvals: Factors associated with observing exposure-efficacy relationships.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e15127